| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 498.318 | 92 |
| GSM780708 | Untreated after 4 days (C2_1) | 419.286 | 90 |
| GSM780709 | Untreated after 4 days (C3_1) | 384.68 | 90 |
| GSM780719 | Untreated after 4 days (C1_2) | 485.319 | 91 |
| GSM780720 | Untreated after 4 days (C2_2) | 470.973 | 91 |
| GSM780721 | Untreated after 4 days (C3_2) | 401.629 | 90 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 455.835 | 91 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 442.285 | 91 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 544.606 | 92 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 501.202 | 92 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 401.032 | 90 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 519.646 | 92 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 409.335 | 90 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 437.096 | 91 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 411.815 | 90 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 382.809 | 89 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 421.499 | 90 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 445.792 | 91 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 389.086 | 90 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 383.44 | 89 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 410.37 | 90 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 342.233 | 89 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 382.348 | 89 |